Analysed JUPITER NEUROSCIENCES INC (JUNS:NASDAQ) News Sources
Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech
20-05-2026
yahoo.com
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
20-05-2026
yahoo.com
D. Boral Capital Acted as Exclusive Placement Agent to Jupiter Neurosciences, Inc. (Nasdaq:JUNS) in Connection with its ~$2 Million Registered Direct Offering
26-05-2026
yahoo.com
PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002
21-07-2026
yahoo.com
Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million
21-07-2026
yahoo.com
Jupiter Neurosciences Signs ALA-002 License Agreement Worth Up to $100 Million (NASDAQ:JUNS)
21-07-2026
advfn.com
Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva
22-07-2026
yahoo.com
What is the current price of JUPITER NEUROSCIENCES INC (JUNS:NASDAQ)?
The current price of JUPITER NEUROSCIENCES INC (JUNS:NASDAQ) is $2.93.
JUPITER NEUROSCIENCES INC (JUNS:NASDAQ) absolute price change since previous trading day?
The absolute price change of JUPITER NEUROSCIENCES INC (JUNS:NASDAQ) since the previous trading day is $-0.08.
JUPITER NEUROSCIENCES INC (JUNS:NASDAQ) percentage price change since previous trading day?
The percentage price change of JUPITER NEUROSCIENCES INC (JUNS:NASDAQ) since the previous trading day is -2.6578%.
What is the most recent average sentiment score for JUPITER NEUROSCIENCES INC (JUNS:NASDAQ)?
The most recent average sentiment score for JUPITER NEUROSCIENCES INC (JUNS:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for JUPITER NEUROSCIENCES INC (JUNS:NASDAQ)?
The most recent sentiment for JUPITER NEUROSCIENCES INC (JUNS:NASDAQ) is .
SEC-8K** Filing Available For JUPITER NEUROSCIENCES INC (JUNS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.